A citation-based method for searching scientific literature

Narmadhaa Siva, Sonal Gupta, Ayam Gupta, Jayendra Nath Shukla, Babita Malik, Nidhi Shukla. 3 Biotech 2021
Times Cited: 4







List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Delivering CRISPR: a review of the challenges and approaches.
Christopher A Lino, Jason C Harper, James P Carney, Jerilyn A Timlin. Drug Deliv 2018
425
75

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
Hongyi Li, Yang Yang, Weiqi Hong, Mengyuan Huang, Min Wu, Xia Zhao. Signal Transduct Target Ther 2020
426
50

History of genome editing: From meganucleases to CRISPR.
Simon E Tröder, Branko Zevnik. Lab Anim 2022
9
50

Viral and nonviral delivery systems for gene delivery.
Nouri Nayerossadat, Talebi Maedeh, Palizban Abas Ali. Adv Biomed Res 2012
401
50


Genome editing with engineered zinc finger nucleases.
Fyodor D Urnov, Edward J Rebar, Michael C Holmes, H Steve Zhang, Philip D Gregory. Nat Rev Genet 2010
50

Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus.
Inés G Muñoz, Jesús Prieto, Sunita Subramanian, Javier Coloma, Pilar Redondo, Maider Villate, Nekane Merino, Marco Marenchino, Marco D'Abramo, Francesco L Gervasio,[...]. Nucleic Acids Res 2011
44
50


ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Thomas Gaj, Charles A Gersbach, Carlos F Barbas. Trends Biotechnol 2013
50

CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off-Target Evaluation, and Strategies to Mitigate Off-Target Effects.
Hakim Manghwar, Bo Li, Xiao Ding, Amjad Hussain, Keith Lindsey, Xianlong Zhang, Shuangxia Jin. Adv Sci (Weinh) 2020
74
50

Optimizing genome editing strategy by primer-extension-mediated sequencing.
Jianhang Yin, Mengzhu Liu, Yang Liu, Jinchun Wu, Tingting Gan, Weiwei Zhang, Yinghui Li, Yaxuan Zhou, Jiazhi Hu. Cell Discov 2019
30
50

Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq.
Beeke Wienert, Stacia K Wyman, Christopher D Richardson, Charles D Yeh, Pinar Akcakaya, Michelle J Porritt, Michaela Morlock, Jonathan T Vu, Katelynn R Kazane, Hannah L Watry,[...]. Science 2019
178
50

CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Ariel Kantor, Michelle E McClements, Robert E MacLaren. Int J Mol Sci 2020
86
50

Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.
George Silva, Laurent Poirot, Roman Galetto, Julianne Smith, Guillermo Montoya, Philippe Duchateau, Frédéric Pâques. Curr Gene Ther 2011
197
50

Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing.
Wenhua Zhou, Haodong Cui, Liming Ying, Xue-Feng Yu. Angew Chem Int Ed Engl 2018
86
50

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
You Lu, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang,[...]. Nat Med 2020
170
50

RNA editing with CRISPR-Cas13.
David B T Cox, Jonathan S Gootenberg, Omar O Abudayyeh, Brian Franklin, Max J Kellner, Julia Joung, Feng Zhang. Science 2017
755
50

CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions.
Abu Hazafa, Muhammad Mumtaz, Muhammad Fras Farooq, Shahid Bilal, Sundas Nasir Chaudhry, Musfira Firdous, Huma Naeem, Muhammad Obaid Ullah, Muhammad Yameen, Muhammad Shahid Mukhtiar,[...]. Life Sci 2020
16
50

Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.
Shahad K Alsaiari, Sachin Patil, Mram Alyami, Kholod O Alamoudi, Fajr A Aleisa, Jasmeen S Merzaban, Mo Li, Niveen M Khashab. J Am Chem Soc 2018
206
50

A cytosine deaminase for programmable single-base RNA editing.
Omar O Abudayyeh, Jonathan S Gootenberg, Brian Franklin, Jeremy Koob, Max J Kellner, Alim Ladha, Julia Joung, Paul Kirchgatterer, David B T Cox, Feng Zhang. Science 2019
172
50

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.
Keiichiro Suzuki, Yuji Tsunekawa, Reyna Hernandez-Benitez, Jun Wu, Jie Zhu, Euiseok J Kim, Fumiyuki Hatanaka, Mako Yamamoto, Toshikazu Araoka, Zhe Li,[...]. Nature 2016
612
50

Multiplex genome engineering using CRISPR/Cas systems.
Le Cong, F Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D Hsu, Xuebing Wu, Wenyan Jiang, Luciano A Marraffini,[...]. Science 2013
50

Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Kristen D Belfield, Eric M Tichy. Am J Health Syst Pharm 2018
46
25

HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease.
Yunfeng Liu, Fangmiao Jing, Woelsung Yi, Avital Mendelson, Patricia Shi, Ronald Walsh, David F Friedman, Caterina Minniti, Deepa Manwani, Stella T Chou,[...]. Blood 2018
25
25

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.
Naoya Uchida, Alexis Leonard, David Stroncek, Sandhya R Panch, Kamille West, Eoghan Molloy, Thomas E Hughes, Sara Hauffe, Tiffani Taylor, Courtney Fitzhugh,[...]. Haematologica 2020
16
25

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Alexis Leonard, John Tisdale, Allistair Abraham. Br J Haematol 2020
13
25

Curative Therapies for Sickle Cell Disease.
Kirshma Khemani, Deeksha Katoch, Lakshmanan Krishnamurti. Ochsner J 2019
12
25

iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.
Dario Melguizo-Sanchis, Yaobo Xu, Dheraj Taheem, Min Yu, Katarzyna Tilgner, Tomas Barta, Katja Gassner, George Anyfantis, Tengfei Wan, Ramu Elango,[...]. Cell Death Dis 2018
19
25

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy.
Elena Vuelta, Ignacio García-Tuñón, Patricia Hernández-Carabias, Lucía Méndez, Manuel Sánchez-Martín. Biology (Basel) 2021
6
25

Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.
Sergei Doulatov, Linda T Vo, Stephanie S Chou, Peter G Kim, Natasha Arora, Hu Li, Brandon K Hadland, Irwin D Bernstein, James J Collins, Leonard I Zon,[...]. Cell Stem Cell 2013
183
25

High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.
Xiao-Bing Zhang, Brian C Beard, Grant D Trobridge, Brent L Wood, George E Sale, Reeteka Sud, R Keith Humphries, Hans-Peter Kiem. J Clin Invest 2008
88
25

Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.
Yan Chen, Ruiting Wen, Zhigang Yang, Zhanghui Chen. Gene Ther 2022
5
25

Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives.
Júlia Teixeira Cottas de Azevedo, Kelen Cristina Ribeiro Malmegrim. Immunol Lett 2020
10
25

Glucose-6-phosphate dehydrogenase deficiency.
Lucio Luzzatto, Mwashungi Ally, Rosario Notaro. Blood 2020
74
25

New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical properties.
Qingwen Zhang, Ronghui Du, Guilherme Rodrigo Reis Monteiro Dos Santos, Revital Yefidoff-Freedman, Andrew Bohm, Jose Halperin, Michael Chorev, Bertal H Aktas. Eur J Med Chem 2020
6
25

Zinc-finger Nucleases: The Next Generation Emerges.
Toni Cathomen, J Keith Joung. Mol Ther 2008
55
25

Biased and Unbiased Methods for the Detection of Off-Target Cleavage by CRISPR/Cas9: An Overview.
Francisco Martin, Sabina Sánchez-Hernández, Alejandra Gutiérrez-Guerrero, Javier Pinedo-Gomez, Karim Benabdellah. Int J Mol Sci 2016
44
25

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, Stefania Bramanti, Barbara Sarina, Angela Granata, Andrea Vai, Claude Lemarie, Catherine Faucher, Bilal Mohty,[...]. Cancer 2015
28
25

Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy.
Rosa Vona, Nadia Maria Sposi, Lorenza Mattia, Lucrezia Gambardella, Elisabetta Straface, Donatella Pietraforte. Antioxidants (Basel) 2021
19
25

De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
Dongxue Mao, Chloe M Reuter, Maura R Z Ruzhnikov, Anita E Beck, Emily G Farrow, Lisa T Emrick, Jill A Rosenfeld, Katherine M Mackenzie, Laurie Robak, Matthew T Wheeler,[...]. Am J Hum Genet 2020
22
25

3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected].
Shi-Jiang Lu, Tim Kelley, Qiang Feng, Allen Chen, Shaul Reuveny, Robert Lanza, Steve K W Oh. Regen Med 2013
20
25

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity.
Claudio Mussolino, Jamal Alzubi, Eli J Fine, Robert Morbitzer, Thomas J Cradick, Thomas Lahaye, Gang Bao, Toni Cathomen. Nucleic Acids Res 2014
113
25

Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.
Richard O Francis, Angelo D'Alessandro, Andrew Eisenberger, Mark Soffing, Randy Yeh, Esther Coronel, Arif Sheikh, Francesca Rapido, Francesca La Carpia, Julie A Reisz,[...]. J Clin Invest 2020
40
25

In vivo CRISPR editing with no detectable genome-wide off-target mutations.
Pinar Akcakaya, Maggie L Bobbin, Jimmy A Guo, Jose Malagon-Lopez, Kendell Clement, Sara P Garcia, Mick D Fellows, Michelle J Porritt, Mike A Firth, Alba Carreras,[...]. Nature 2018
188
25

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.
Jacob Hanna, Marius Wernig, Styliani Markoulaki, Chiao-Wang Sun, Alexander Meissner, John P Cassady, Caroline Beard, Tobias Brambrink, Li-Chen Wu, Tim M Townes,[...]. Science 2007
996
25

In utero nanoparticle delivery for site-specific genome editing.
Adele S Ricciardi, Raman Bahal, James S Farrelly, Elias Quijano, Anthony H Bianchi, Valerie L Luks, Rachael Putman, Francesc López-Giráldez, Süleyman Coşkun, Eric Song,[...]. Nat Commun 2018
85
25

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Elliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, Russell E Ware, Videlis Nduba, Amal El-Beshlawy, Hoda Hassab, Maureen M Achebe, Salam Alkindi, R Clark Brown,[...]. N Engl J Med 2019
247
25

CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Ansar Karimian, Khalil Azizian, Hadi Parsian, Sona Rafieian, Vahid Shafiei-Irannejad, Maryam Kheyrollah, Mehdi Yousefi, Maryam Majidinia, Bahman Yousefi. J Cell Physiol 2019
54
25

Emerging therapies in sickle cell disease.
Amina Nardo-Marino, Valentine Brousse, David Rees. Br J Haematol 2020
20
25

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.
Matthew M Hsieh, Courtney D Fitzhugh, John F Tisdale. Blood 2011
89
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.